Larvol Delta - New-Formulation-Study-of-Inupadenant-EOS100850-in-Patients-with-Cancer

inupadenant (EOS-850) - iTeos

http://clinicaltrials.gov/ct2/show/NCT05117177

Sep 21, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next